Taparia Tools Limited (BOM:505685)
28.04
+1.33 (4.98%)
At close: Jul 24, 2025
Ligand Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, Taparia Tools had annual revenue of 9.13B INR with 10.18% growth. Taparia Tools had revenue of 2.43B in the quarter ending March 31, 2025, with 10.61% growth.
Revenue
9.13B
Revenue Growth
+10.18%
P/S Ratio
0.05
Revenue / Employee
31.70M
Employees
288
Market Cap
425.61M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 9.13B | 843.55M | 10.18% |
Mar 31, 2024 | 8.29B | 640.47M | 8.38% |
Mar 31, 2023 | 7.64B | 968.68M | 14.51% |
Mar 31, 2022 | 6.68B | 1.32B | 24.54% |
Mar 31, 2021 | 5.36B | 645.44M | 13.69% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,765.41B |
HDFC Bank | 2,736.06B |
Bharti Airtel | 1,729.85B |
Tata Consultancy Services | 2,561.48B |
ICICI Bank | 2,054.85B |
State Bank of India | 3,429.39B |
Infosys | 1,672.76B |
Hindustan Unilever | 639.28B |